Novo Nordisk Foundation Worldwide
2026
Information
The Regenerative Medicine Catalyst Grants are competitive grants to provide catalytic funding for translational research projects that advance stem cell-based and other regenerative medicine therapies towards clinical development. The programme prioritises projects addressing thematic areas such as allogeneic cell therapy, analytical methods for stem cell-based medicines, engineering biomaterials and devices, and clinical development and manufacturability of cell therapies. The grants aim to strengthen the Nordic regenerative medicine ecosystem, promote international collaboration, and lower time- and cost-barriers to therapy development.
Benefits
Grant funding to support translational research projects, promotion of international collaboration, and support to advance projects towards clinical development.
Eligibility
The main applicant must be anchored and have their primary employment and research group at a university, hospital, or other non-profit research institution in a Nordic country (Denmark, Sweden, Norway, Finland, Iceland, Greenland, Faroe Islands).
Always verify details on the official website before applying. Found an error? Tell us.